Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients Diagnosed”

227 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 227 results

Not applicableTemporarily pausedNCT04474652
What this trial is testing

Guide for Prioritisation of Patients for Referral to Breast Clinics

Who this might be right for
Breast Cancer
The Leeds Teaching Hospitals NHS Trust 4,000
Testing effectiveness (Phase 2)Study completedNCT01201265
What this trial is testing

Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 40
Not applicableActive Not RecruitingNCT03429907
What this trial is testing

An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer

Who this might be right for
Malignant Neoplasm of Breast
M.D. Anderson Cancer Center 62
Very early researchWithdrawnNCT04630210
What this trial is testing

Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven
Not applicableLooking for participantsNCT06813053
What this trial is testing

A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
University of Colorado, Denver 60
Testing effectiveness (Phase 2)UnknownNCT00083018
What this trial is testing

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 100
Not applicableStudy completedNCT00900133
What this trial is testing

Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107
What this trial is testing

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Who this might be right for
Breast CarcinomaBreast LumpEdema+8 more
M.D. Anderson Cancer Center 42
Early research (Phase 1)Not Yet RecruitingNCT07300475
What this trial is testing

Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Washington University School of Medicine 30
Large-scale testing (Phase 3)Study completedNCT00262899
What this trial is testing

Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions

Who this might be right for
Breast CancerPsychosocial Effects of Cancer and Its Treatment
Georgetown University 331
Early research (Phase 1)Study completedNCT01089998
What this trial is testing

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations

Who this might be right for
Diagnostic Imaging
Life Molecular Imaging SA 35
Not applicableStudy completedNCT02449993
What this trial is testing

Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy

Who this might be right for
Breast Cancer
BioNTech Diagnostics GmbH 101
Early research (Phase 1)Looking for participantsNCT06337084
What this trial is testing

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultBladder CancerUrothelial Carcinoma+6 more
Monopar Therapeutics 12
Not applicableStudy completedNCT00773669
What this trial is testing

Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007

Who this might be right for
Breast Cancer
Summa Health System 24
Not applicableLooking for participantsNCT07214883
What this trial is testing

UCF MammoChat: Image Repository

Who this might be right for
Breast CancerBreast Cancer AwarenessBreast Cancer Detection+3 more
University of Central Florida 20,000
Not applicableWithdrawnNCT03176888
What this trial is testing

Health Benefits of HIT for Breast Cancer Patients

Who this might be right for
Breast Cancer
University of Stirling
Testing effectiveness (Phase 2)Active Not RecruitingNCT02883062
What this trial is testing

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage II Breast Cancer AJCC v6 and v7Stage III Breast Cancer AJCC v7+1 more
National Cancer Institute (NCI) 67
Not applicableStudy completedNCT00089323
What this trial is testing

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,630
Testing effectiveness (Phase 2)Active Not RecruitingNCT04478279
What this trial is testing

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Who this might be right for
GlioblastomaMelanoma Stage IVBreast Cancer+11 more
Sapience Therapeutics 125
Not applicableWithdrawnNCT02168179
What this trial is testing

KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituSkin Reactions Secondary to Radiation TherapyStage IA Breast Cancer+4 more
Wake Forest University Health Sciences
Load More Results